nelotanserin,
NELOTANSERIN,
839713-36-9,
UNII-4ZA73QEW2P,
4ZA73QEW2P,
1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea,
APD125,
CHEMBL598172,
APD-125,
1-[3-(4-BROMO-1-METHYL-1H-PYRAZOL-5-YL)-4-METHOXYPHENYL]-3-(2,4-DIFLUOROPHENYL)UREA,
1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea,
N-[3-(4-bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-N'-(2,4-difluorophenyl)-Urea,
Nelotanserin [USAN:INN],
Nelotanserin (USAN/INN),
SCHEMBL2345325,
APD 125,
DTXSID40232868,
COSPVUFTLGQDQL-UHFFFAOYSA-N,
BCP24992,
BDBM50324541,
MFCD16619341,
ZINC38239930,
CS-5984,
DB12555,
SB19023,
1-[3-(4-bromo-2-methyl-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluorophenyl)urea,
AK206123,
AN-27211,
AS-30117,
HY-10559,
D09645,
713B369,
1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea,
1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea,
D0GJ7B,
CID11683556,
Urea, N-[3-(4-bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-N'-(2,4-difluorophenyl)-,